rss
J Clin Pathol 2009;62:1016-1020 doi:10.1136/jcp.2009.066977
  • Original article

Proteins from the Wnt pathway are involved in the pathogenesis and progression of mammary phyllodes tumours

  1. R Z Karim1,2,3,
  2. S K Gerega4,
  3. Y H Yang4,5,
  4. L Horvath6,7,
  5. A Spillane8,
  6. H Carmalt9,
  7. R A Scolyer1,2,3,
  8. C S Lee1,3,10,11,12
  1. 1
    Department of Anatomical Pathology, Royal Prince Alfred Hospital, Sydney, NSW, Australia
  2. 2
    Cancer Institute NSW, Sydney, NSW, Australia
  3. 3
    Discipline of Pathology, Faculty of Medicine, The University of Sydney, Sydney, NSW, Australia
  4. 4
    Sydney Bioinformatics, The University of Sydney, Sydney, NSW, Australia
  5. 5
    School of Mathematics and Statistics, The University of Sydney, Sydney, NSW, Australia
  6. 6
    Sydney Cancer Centre, Sydney, NSW, Australia
  7. 7
    Garvan Institute, Sydney, NSW, Australia
  8. 8
    Discipline of Surgery, Faculty of Medicine, The University of Sydney, Sydney, NSW, Australia
  9. 9
    Visiting Breast Surgeon, Royal Prince Alfred Hospital, Sydney, NSW, Australia
  10. 10
    Department of Anatomical Pathology, Liverpool Hospital, Sydney, NSW, Australia
  11. 11
    Discipline of Pathology, School of Medicine, The University of Western Sydney, Sydney, NSW, Australia
  12. 12
    Cancer Pathology, Bosch Institute, The University of Sydney, Sydney, NSW, Australia
  1. Correspondence to Dr R Z Karim, Department of Anatomical Pathology, Royal Prince Alfred Hospital, Camperdown, NSW 2050, Sydney, Australia; rooshdiya.karim{at}email.cs.nsw.gov.au
  • Accepted 30 July 2009

Abstract

Background: The Wnt pathway is important in cell signalling transduction and is involved in the pathogenesis of multiple tumour types. A comprehensive analysis of the expression of Wnt signalling pathway proteins in mammary phyllodes tumours (PTs) has not been previously performed.

Aims: To evaluate the immunohistochemical expression of Wnt pathway proteins in a cohort of PTs, to determine their role in tumour pathogenesis and to identify any associations with patient outcome.

Methods: 65 PTs (34 benign, 23 borderline and 8 malignant) diagnosed at a single institution between 1990 and 2006 were analysed. Immunohistochemical stains were performed on tissue microarrays for β-catenin, Wnt1, Wnt5a, SFRP4 and E-cadherin. Stroma and epithelium were scored separately.

Results: Stromal cytoplasmic Wnt5a and SFRP4 expression showed significant progressive increases in expression with increasing grade (p = 0.002 and p = 0.02 respectively). Epithelial membranous and stromal nuclear β-catenin, epithelial cytoplasmic Wnt1 and epithelial E-cadherin all also showed increasing expression with increasing tumour grade, however, the differences were not significant. Disease-free survival was significantly decreased (p = 0.0017) with positive epithelial E-cadherin staining.

Conclusions: Results suggest that alterations in the Wnt pathway are important in the progression and in the epithelial and stromal interactions in PTs. They have important implications for understanding the pathogenesis of these uncommon but clinically important tumours.

Footnotes

  • Competing interests None.

  • Ethics approval Ethics approval was obtained.

  • Provenance and peer review Not commissioned; externally peer reviewed.

This Article

  1. Abstract
  2. Full text
  3. PDF

Responses

  1. Submit a response
  2. No responses published

Register for free content

The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.

Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.